Brief: Cambium Bio Signs MoU With Locus Cell For Manufacturing Of Elate Ocular
30/09/2025 11:25
Sept 30 (Reuters) - Cambium Bio Ltd CMB.AX: SIGNS MOU WITH LOCUS CELL FOR MANUFACTURING OF ELATE OCULAR Further company coverage: CMB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cambium Bio
See all newsAustralia's Cambium Bio hits near three-month high on share placement at premium
Brief: Cambium Bio Appoints Olga Smejkalova As Company Secretary
Australia's Cambium Bio gains after premium share placement
Brief: Cambium Bio Raises A$1 MLN At A$0.48 Per Share
Brief: Cambium Bio Receives A$2.4 Million Investment From Zheng Yang Biomedical Technology